2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
-
- Coletta Barrett
- ACC/AHA Representative.
-
- James R. Edgerton
- STS Representative.
-
- Kenneth A. Ellenbogen
- Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendix 1 for detailed information.
-
- Michael R. Gold
- Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendix 1 for detailed information.
-
- Nora F. Goldschlager
- ACC/AHA Representative.
-
- Robert M. Hamilton
- PACES Representative.
-
- José A. Joglar
- ACC/AHA Task Force on Clinical Practice Guidelines Liaison.
-
- Robert J. Kim
- ACC/AHA Representative.
-
- Richard Lee
- AATS Representative.
-
- Joseph E. Marine
- HRS Representative.
-
- Christopher J. McLeod
- ACC/AHA Representative.
-
- Keith R. Oken
- ACC/AHA Representative.
-
- Kristen K. Patton
- ACC/AHA Representative.
-
- Cara N. Pellegrini
- Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendix 1 for detailed information.
-
- Kimberly A. Selzman
- ACC/AHA Representative.
-
- Annemarie Thompson
- ACC/AHA Representative.
-
- Paul D. Varosy
- ACC/AHA Performance Measures Representative.
収録刊行物
-
- Circulation
-
Circulation 140 (8), 2019-08-20
Ovid Technologies (Wolters Kluwer Health)